Document Detail


Levodopa challenge test and (123) I-metaiodobenzylguanidine scintigraphy for diagnosing Parkinson's disease.
MedLine Citation:
PMID:  23410225     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
OBJECTIVES: To explore the possibility of a generally applicable tool for the immediate diagnosis of Parkinson's disease (PD) in its early stage, we compared the sensitivity and specificity of an acute levodopa challenge test with that of (123) I-metaiodobenzylguanidine (MIBG) myocardial scintigraphy. MATERIALS AND METHODS: A consecutive series of 45 patients with extrapyramidal symptoms were recruited to the acute levodopa challenge and evaluated for improvement by use of the Unified Parkinson's Disease Rating Scale motor scores. Of these patients, 32 of them were also examined by MIBG scintigraphy. The patients were followed up for at least 24 months, and 22 patients were diagnosed as having clinically definite PD. RESULTS: The sensitivity and specificity of the acute levodopa challenge test to predict clinical diagnosis of PD were 81.8% and 81.8%, respectively, which were better than those obtained by MIBG scintigraphy (62.5% and 62.5%). In both early- and middle-stages of PD, the test gave better sensitivity than MIBG scintigraphy. CONCLUSIONS: Considering that the well-established and frequently referred clinical diagnostic criteria require longitudinal observation for at least 24 months, the acute levodopa challenge test can be used as an immediate diagnostic tool for PD with sensitivity and specificity comparable to those of MIBG.
Authors:
S Asayama; R Wate; S Kaneko; T Asayama; M Oki; A Tsuge; M Nagashima; J Morita; S Nakamura; M Nakamura; M Nishii; K Fujita; A Saito; S Nakano; H Ito; H Kusaka
Related Documents :
23975945 - Pre-hospital discharge testing of defibrillator without anesthesia: effects on psycholo...
24893135 - Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline.
23452275 - The impact of serum based proteomic mass spectrometry test on treatment recommendations...
17660145 - Evaluation and improvement strategy of analytical turnaround time in the stat laboratory.
11971105 - Quantitative functional measures in ms: what is a reliable change?
22845045 - Comparison of the antipsoriatic effect and tolerability of calcipotriol-containing prod...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2013-2-15
Journal Detail:
Title:  Acta neurologica Scandinavica     Volume:  -     ISSN:  1600-0404     ISO Abbreviation:  Acta Neurol. Scand.     Publication Date:  2013 Feb 
Date Detail:
Created Date:  2013-2-15     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0370336     Medline TA:  Acta Neurol Scand     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
© 2013 John Wiley & Sons A/S.
Affiliation:
Department of Neurology, Kansai Medical University, Moriguchi, Osaka, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Quantitative proteomics reveals distinct differences in the protein content of outer membrane vesicl...
Next Document:  The R156H variation in IL-12R?1 is not a mutation.